![tribune tribune](https://i.tribune.com.pk/media/images/PR-cover1666082598-0/PR-cover1666082598-0.jpg)
In an effort to facilitate fruitful discussions among health-tech experts, Saman-e-Shifa Foundation and Easy Health Tech recently hosted a conference at Health Asia with MEDZnMORE as a diamond sponsor.
Among the leaders who attended the conference held at the Expo Center Karachi were Asad Khan (CEO & Co-founder MEDZnMORE), Saad Khawar (Co-founder MEDZnMORE), Furquan Kidwai (CEO Dawaai.pk), Farhan Essa Abdullah (CEO Dr Essa Laboratory and Diagnostic Center), Dr. Shahid Noor (Chairman Saman-e-Shifa Foundation), Dr. Rafiq Khanani (CEO Easy Health Tech), Omer Abedin (Project Director NIC Karachi) and others.
In various keynote speeches, panel discussions, and chat sessions, the conference shed light on the future of the healthtech industry in Pakistan, and the importance of providing affordable and accessible healthcare for all Pakistanis.
MEDZnMORE's CEO Asad Khan delivered a keynote speech to the audience concerning healthcare on a global scale and providing services to underserved communities.
A special focus was also placed on the importance of healthcare services in frontier markets. Co-founder of MEDZnMORE, Saad Khawar discussed the hurdles and challenges the industry and customers face in Pakistan.
MEDZnMORE is a leading health-tech startup that provides easy access to quality healthcare in Pakistan.
Founded in 2020, the online platform has served customers across Pakistan. They have invested heavily in building purpose-built temperature-controlled warehouses across Pakistan to seamlessly fulfil operational needs.
MEDZnMORE has previously raised $11.5 million as part of its pre-series A round, making it Pakistan's largest health-tech company. The startup has partnered with leading conferences as well as incubated a number of projects aimed at improving access to healthcare products for audiences.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ